Company news
Adhera Therapeutics Inc. news in 2019
Adhera Therapeutics Inc.'s news releases, calls and decks from 2019, newest first.
Adhera Therapeutics Announces Third Quarter 2019 Financial Results and Operational Highlights
November 18, 2019
Adhera Therapeutics Announces Termination of Tender Offer for Preferred Stock
September 26, 2019
Adhera Therapeutics and Indegene Announce Next Gen Commercialization Partnership
September 9, 2019
Adhera and Allegis Pharma Announce Co-Promotion Agreement
September 5, 2019
Adhera Therapeutics Announces Termination of Tender Offer for Warrants
July 2, 2019
Adhera Therapeutics Appoints Nancy Phelan as Chief Executive Officer
April 4, 2019
Adhera Therapeutics and Alyvant Enter into Digital Co-Promotion Agreement for Prestalia
March 3, 2019
Adhera Therapeutics' DyrctAxessTM Platform Helps 78% of Patients Adhere to PRESTALIA(R); Achieves Exceptionally High Level of Drug Adherence to an Antihypertensive Medication
February 5, 2019